BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7961548)

  • 1. Depression in the medically ill: choosing an antidepressant.
    Cunningham LA
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():90-7; discussion 98-100. PubMed ID: 7961548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant effectiveness in severe depression and melancholia.
    Schatzberg AF
    J Clin Psychiatry; 1999; 60 Suppl 4():14-21; discussion 22. PubMed ID: 10086479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.
    Alexopoulos GS; Katz IR; Reynolds CF; Carpenter D; Docherty JP;
    Postgrad Med; 2001 Oct; Spec No Pharmacotherapy():1-86. PubMed ID: 17205639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients.
    Salzman C
    J Clin Psychiatry; 1999; 60 Suppl 20():30-3. PubMed ID: 10513856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mergers and acquisitions among psychotropics: antidepressant takeover of anxiety may now be complete.
    Stahl SM
    J Clin Psychiatry; 1999 May; 60(5):282-3. PubMed ID: 10362433
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressant options: venlafaxine in perspective.
    Thase ME
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antidepressant drugs and the treatment of depression in the medically ill patient.
    Stoudemire A
    Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of depression in the medically ill.
    Beliles K; Stoudemire A
    Psychosomatics; 1998; 39(3):S2-19. PubMed ID: 9664784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical symptoms of depression: unmet needs in special populations.
    Stewart DE
    J Clin Psychiatry; 2003; 64 Suppl 7():12-6. PubMed ID: 12755647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and treatment of late-life depression.
    Rothschild AJ
    J Clin Psychiatry; 1996; 57 Suppl 5():5-11. PubMed ID: 8647792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary trends in the pharmacotherapeutic management of depression.
    Nemeroff CB
    J Clin Psychiatry; 1994 Dec; 55 Suppl():3-15; discussion 16-7. PubMed ID: 7814356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of remission as the new standard in the treatment of depression.
    Nierenberg AA; Wright EC
    J Clin Psychiatry; 1999; 60 Suppl 22():7-11. PubMed ID: 10634349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 18():23-9. PubMed ID: 9840195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations in choosing an antidepressant.
    Kingsbury SJ; Simpson GM
    Psychiatr Serv; 2001 Nov; 52(11):1435-6. PubMed ID: 11684736
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular safety in depressed patients: focus on venlafaxine.
    Feighner JP
    J Clin Psychiatry; 1995 Dec; 56(12):574-9. PubMed ID: 8530334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.